{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:05:00Z","timestamp":1792069500191,"version":"4.4.0"},"reference-count":71,"publisher":"American Association for Cancer Research (AACR)","issue":"18","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000799"],"award-info":[{"award-number":["32000799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203611"],"award-info":[{"award-number":["82203611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017529","name":"Major Scientific and Technological Project of Zhejiang Province","doi-asserted-by":"publisher","award":["D25H300005"],"award-info":[{"award-number":["D25H300005"]}],"id":[{"id":"10.13039\/501100017529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005199","name":"Chinese Medicine Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["GZY-KJS-ZJ-2025-072"],"award-info":[{"award-number":["GZY-KJS-ZJ-2025-072"]}],"id":[{"id":"10.13039\/501100005199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02058"],"award-info":[{"award-number":["2025C02058"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2023C03010"],"award-info":[{"award-number":["2023C03010"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Y24H160082"],"award-info":[{"award-number":["Y24H160082"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H160028"],"award-info":[{"award-number":["LQ21H160028"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972367"],"award-info":[{"award-number":["81972367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>PD-1 restrains effective killing of cancer cells by the immune system and is predominantly located on the surface of T cells or other immune cells. However, cancer cells also express PD-1 to varying degrees, which is commonly associated with a poor prognosis. In this study, we investigated the regulation and function of PD-1 expression in prostate cancer and revealed the impact on the tumor microenvironment. PD-1 expression in cancer cells positively correlated with Gleason grade and metastasis but negatively correlated with CD8+ T-cell infiltration in patients with prostate cancer. Prostate cancer cells secreted PD-1 in exosomes that enhanced the activity of myeloid-derived suppressor cells by activating JAK\/STAT3 signaling. The activated myeloid-derived suppressor cells in turn reduced the infiltration of CD8+ T cells within the tumor, promoting tumor immune evasion. The ubiquitin-specific peptidase 7 (USP7) induced deubiquitination and elevated the abundance of PD-1 in prostate cancer, and USP7 inhibition sensitized prostate cancer tumors to anti\u2013PD-1 antibody treatment. Given the modest efficacy of current immunotherapeutic approaches for prostate cancer, strategies to inhibit the secretion of PD-1\u2013bearing exosomes or USP7 function may emerge as promising immunostimulatory interventions for treating prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>PD-1 is elevated in prostate cancer by USP7 and secreted in exosomes to activate myeloid-derived suppressor cells and shape an immune-suppressive microenvironment, providing therapeutic targets to improve immunotherapy efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-3748","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T11:18:09Z","timestamp":1753269489000},"page":"3435-3453","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prostate Cancer Cells Secrete PD-1 in Exosomes to Enhance Myeloid-Derived Suppressor Cell Activity and Promote Tumor Immune Evasion"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-077X","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"first","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2279-6931","authenticated-orcid":false,"given":"Weiwu","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5447-8978","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2901-8850","authenticated-orcid":false,"given":"Qian","family":"He","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6369-1317","authenticated-orcid":false,"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7828-7665","authenticated-orcid":false,"given":"Jiayu","family":"Han","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3119-4360","authenticated-orcid":false,"given":"Peng","family":"Gao","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7181-5455","authenticated-orcid":false,"given":"Kunyu","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7295-759X","authenticated-orcid":false,"given":"Haoze","family":"Xie","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."},{"name":"2School of Medicine, Shaoxing University, Shaoxing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7494-5554","authenticated-orcid":false,"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1956-5391","authenticated-orcid":false,"given":"Yining","family":"Guo","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."},{"name":"3College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-1147","authenticated-orcid":false,"given":"Wenhao","family":"Guo","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9311-4297","authenticated-orcid":false,"given":"Haofei","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8197-3727","authenticated-orcid":false,"given":"Jing","family":"Le","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3288-3661","authenticated-orcid":false,"given":"Ruichen","family":"Zang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7872-6103","authenticated-orcid":false,"given":"Sisi","family":"Mo","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1517-7932","authenticated-orcid":false,"given":"Haobo","family":"Fan","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1627-753X","authenticated-orcid":false,"given":"Xiaoxiao","family":"Zhu","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3049-052X","authenticated-orcid":false,"given":"Xinrong","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-2378","authenticated-orcid":false,"given":"Fengbin","family":"Gao","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1351-7896","authenticated-orcid":false,"given":"Yanlan","family":"Yu","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-3618","authenticated-orcid":false,"given":"Guoqing","family":"Ding","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."},{"name":"4National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-1337","authenticated-orcid":false,"given":"Yicheng","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."},{"name":"2School of Medicine, Shaoxing University, Shaoxing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2025091503065046500_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025091503065046500_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025091503065046500_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4111\/icu.20210369","article-title":"Immunotherapy for prostate cancer: requirements for a successful regime transfer","volume":"63","author":"Jeong","year":"2022","journal-title":"Invest Clin Urol"},{"key":"2025091503065046500_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: inflammatory storms","volume":"20","author":"de Bono","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025091503065046500_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"2025091503065046500_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2025091503065046500_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fimmu.2020.01526","article-title":"Myeloid-derived suppressor cells in colorectal cancer","volume":"11","author":"Sieminska","year":"2020","journal-title":"Front Immunol"},{"key":"2025091503065046500_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fimmu.2019.00771","article-title":"Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression","volume":"10","author":"Bruno","year":"2019","journal-title":"Front Immunol"},{"key":"2025091503065046500_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative gleason grading in prostate biopsies and prostatectomy specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"key":"2025091503065046500_bib10","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1002\/cncr.27670","article-title":"The quantitative gleason score improves prostate cancer risk assessment","volume":"118","author":"Reese","year":"2012","journal-title":"Cancer"},{"key":"2025091503065046500_bib11","first-page":"137A","article-title":"The impact of the 2005 international society of urological pathology (ISUP) consensus conference on standard Gleason grading of prostatic carcinoma","volume":"87","author":"Billis","year":"2007","journal-title":"Part 2. Laboratory Investigation"},{"key":"2025091503065046500_bib12","doi-asserted-by":"crossref","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"2025091503065046500_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"2025091503065046500_bib14","doi-asserted-by":"crossref","first-page":"e1408747","DOI":"10.1080\/2162402X.2017.1408747","article-title":"Blockade of tumor-expressed PD-1 promotes lung cancer growth","volume":"7","author":"Du","year":"2018","journal-title":"OncoImmunology"},{"key":"2025091503065046500_bib15","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.1921445117","article-title":"Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025091503065046500_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"2025091503065046500_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","article-title":"Proteasome inhibitors: valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol"},{"key":"2025091503065046500_bib18","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","article-title":"Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer","volume":"40","author":"Qiu","year":"2021","journal-title":"Oncogene"},{"key":"2025091503065046500_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"key":"2025091503065046500_bib20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/14756366.2020.1754814","article-title":"Advances in the discovery of exosome inhibitors in cancer","volume":"35","author":"Zhang","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2025091503065046500_bib21","doi-asserted-by":"crossref","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"2025091503065046500_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"2025091503065046500_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2025091503065046500_bib24","doi-asserted-by":"crossref","first-page":"e20220011","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: a consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J Exp Med"},{"key":"2025091503065046500_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025091503065046500_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"2025091503065046500_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"2025091503065046500_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/cells11020310","article-title":"Myeloid-derived suppressor cells in solid tumors","volume":"11","author":"Ma","year":"2022","journal-title":"Cells"},{"key":"2025091503065046500_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(97)00195-1","article-title":"Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator","volume":"82","author":"Fujii","year":"1998","journal-title":"J Neuroimmunology"},{"key":"2025091503065046500_bib30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jcmm.16885","article-title":"Liposomal phytohemagglutinin: in vivo T-cell activator as a novel pan-cancer immunotherapy","volume":"26","author":"Alhallak","year":"2022","journal-title":"J Cell Mol Med"},{"key":"2025091503065046500_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.184.3.923","article-title":"Constitutive class I-restricted exogenous presentation of self antigens in vivo","volume":"184","author":"Kurts","year":"1996","journal-title":"J Exp Med"},{"key":"2025091503065046500_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-1711.2000.00889.x","article-title":"Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection","volume":"78","author":"Clarke","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"2025091503065046500_bib33","doi-asserted-by":"crossref","first-page":"113424","DOI":"10.1016\/j.celrep.2023.113424","article-title":"Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+ T cell","volume":"42","author":"Xu","year":"2023","journal-title":"Cell Rep"},{"key":"2025091503065046500_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ccell.2023.04.003","article-title":"Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators","volume":"41","author":"Obradovic","year":"2023","journal-title":"Cancer Cell"},{"key":"2025091503065046500_bib35","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1158\/0008-5472.CAN-06-4639","article-title":"A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model","volume":"67","author":"Ko","year":"2007","journal-title":"Cancer Res"},{"key":"2025091503065046500_bib36","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2025091503065046500_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2025091503065046500_bib38","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"2025091503065046500_bib39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","article-title":"CD300ld on neutrophils is required for tumour-driven immune suppression","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"2025091503065046500_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jitc-2021-004384","article-title":"STAT3 inhibitor napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice","volume":"10","author":"Bitsch","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025091503065046500_bib41","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","article-title":"Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells","volume":"166","author":"Gabrilovich","year":"2001","journal-title":"J Immunol"},{"key":"2025091503065046500_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41590-018-0237-5","article-title":"Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity","volume":"19","author":"Knier","year":"2018","journal-title":"Nat Immunol"},{"key":"2025091503065046500_bib43","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J Exp Med"},{"key":"2025091503065046500_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0103629","article-title":"TLR9 ligands induce S100A8 in macrophages via a STAT3-Dependent pathway which requires IL-10 and PGE2","volume":"9","author":"Hsu","year":"2014","journal-title":"PLoS One"},{"key":"2025091503065046500_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.07.015","article-title":"S100A8\/A9: from basic science to clinical application","volume":"167","author":"Pruenster","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2025091503065046500_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smim.2017.12.004","article-title":"Neutrophils and PMN-MDSC: their biological role and interaction with stromal cells","volume":"35","author":"Zhou","year":"2018","journal-title":"Semin Immunol"},{"key":"2025091503065046500_bib47","doi-asserted-by":"crossref","first-page":"21123","DOI":"10.1074\/jbc.M110675200","article-title":"Regulation of T cell receptor CD3zeta chain expression by L-arginine","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J Biol Chem"},{"key":"2025091503065046500_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell Immunol"},{"key":"2025091503065046500_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J Exp Med"},{"key":"2025091503065046500_bib50","doi-asserted-by":"crossref","first-page":"108114","DOI":"10.1016\/j.pharmthera.2022.108114","article-title":"Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy","volume":"235","author":"Joshi","year":"2022","journal-title":"Pharmacol Ther"},{"key":"2025091503065046500_bib51","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","article-title":"Gut microbiota modulate T cell trafficking into human colorectal cancer","volume":"67","author":"Cremonesi","year":"2018","journal-title":"Gut"},{"key":"2025091503065046500_bib52","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/hep.32062","article-title":"IL-1\u03b2-induced elevation of solute carrier family 7 member 11 promotes hepatocellular carcinoma metastasis through Up-regulating programmed death ligand 1 and colony-stimulating factor 1","volume":"74","author":"He","year":"2021","journal-title":"Hepatology"},{"key":"2025091503065046500_bib53","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","article-title":"IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1","volume":"195","author":"Hsu","year":"2015","journal-title":"J Immunol"},{"key":"2025091503065046500_bib54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2019-319200","article-title":"STAT3 activation through IL-6\/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis","volume":"69","author":"Heichler","year":"2020","journal-title":"Gut"},{"key":"2025091503065046500_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1126\/sciadv.aay4458","article-title":"Molecular mechanism of SHP2 activation by PD-1 stimulation","volume":"6","author":"Marasco","year":"2020","journal-title":"Sci Adv"},{"key":"2025091503065046500_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41586-020-2851-2","article-title":"Immune receptor inhibition through enforced phosphatase recruitment","volume":"586","author":"Fernandes","year":"2020","journal-title":"Nature"},{"key":"2025091503065046500_bib57","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80384","article-title":"Basic medical research award. The ubiquitin system","volume":"6","author":"Hershko","year":"2000","journal-title":"Nat Med"},{"key":"2025091503065046500_bib58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"2025091503065046500_bib59","doi-asserted-by":"crossref","first-page":"28239","DOI":"10.1073\/pnas.2004570117","article-title":"KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression","volume":"117","author":"Zhou","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025091503065046500_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025091503065046500_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"Jvenn: an interactive venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"2025091503065046500_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dnarep.2019.02.005","article-title":"USP7: structure, substrate specificity, and inhibition","volume":"76","author":"Pozhidaeva","year":"2019","journal-title":"DNA Repair"},{"key":"2025091503065046500_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gendis.2020.10.004","article-title":"The USP7 protein interaction network and its roles in tumorigenesis","volume":"9","author":"Al-Eidan","year":"2022","journal-title":"Genes Dis"},{"key":"2025091503065046500_bib64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(02)01199-6","article-title":"Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde","volume":"111","author":"Hu","year":"2002","journal-title":"Cell"},{"key":"2025091503065046500_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41421-019-0089-7","article-title":"Structural basis for the recognition of K48-linked Ub chain by proteasomal receptor Rpn13","volume":"5","author":"Liu","year":"2019","journal-title":"Cell Discov"},{"key":"2025091503065046500_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"key":"2025091503065046500_bib67","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.immuni.2024.05.004","article-title":"Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression","volume":"57","author":"Liang","year":"2024","journal-title":"Immunity"},{"key":"2025091503065046500_bib68","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s12276-022-00898-7","article-title":"Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"key":"2025091503065046500_bib69","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1038\/s41598-020-62076-x","article-title":"Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism","volume":"10","author":"Schauer","year":"2020","journal-title":"Sci Rep"},{"key":"2025091503065046500_bib70","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1038\/cddis.2013.400","article-title":"USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis","volume":"4","author":"Fan","year":"2013","journal-title":"Cell Death Dis"},{"key":"2025091503065046500_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-3748\/3633206\/can-24-3748.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/18\/3435\/3647688\/can-24-3748.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/18\/3435\/3647688\/can-24-3748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:07:28Z","timestamp":1757920048000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/18\/3435\/764454\/Prostate-Cancer-Cells-Secrete-PD-1-in-Exosomes-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":71,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-3748","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30125971","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125950","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125962","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125956","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125968","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125959","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125974","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30125965","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8034712","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}